Fig. 3: Survival analysis.

A Comparison of the prognosis of patients with GI-DHL/THL and GI-DLBCL. Two of 15 patients in GI-DHL/THL group were lost to follow-up. B Comparison of the prognosis of patients with overall DHL/THLs and DLBCLs. Three of 57 patients in DHL/THL group were lost to follow-up, including 2 cases from GI and 1 case from lymph nodes.